Last reviewed: June 20, 2026

Last updated: June 20, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

When choosing a weight-loss therapy, understanding how semaglutide and tirzepatide work—and which may be better for your body—matters. Semaglutide activates one hormone receptor (GLP-1), while tirzepatide activates two (GLP-1 and GIP), which is why clinical trials show tirzepatide can deliver greater average weight loss for many patients. PlexusDx offers compounded versions of both medications, plus genetic testing to help you pick the right fit.

How Semaglutide and Tirzepatide Work Differently

Semaglutide mimics glucagon-like peptide-1 (GLP-1), a hormone that signals fullness to your brain and slows stomach emptying. This single-pathway approach has helped millions lose weight by reducing hunger and food cravings. The medication has been studied for nearly a decade in weight-loss settings, building a strong safety record.

Tirzepatide activates both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors—a dual-hormone strategy. By triggering two separate appetite-control pathways simultaneously, tirzepatide may enhance metabolic effects beyond what a single-pathway drug can achieve. This combination explains why some patients experience more rapid or sustained weight loss with tirzepatide.

Clinical Trial Results: Comparing Weight Loss Outcomes

Head-to-head trials show meaningful differences between the two. Semaglutide users in Phase 3 trials lost an average of 15–17% of baseline body weight over 68 weeks. Tirzepatide demonstrated stronger outcomes in the SURMOUNT trials, with patients losing 20–22% of baseline weight at higher doses over similar timeframes. Individual results vary based on genetics, adherence, and lifestyle.

Neither medication is universally 'better'—response depends on your genetic predispositions and how your body metabolizes each compound. PlexusDx's Precision Peptide Genetic Test examines variants in GLP1R, GIPR, FTO, and MC4R genes to predict whether you may respond more robustly to one therapy over another, helping you avoid trial-and-error dosing.

Cost and Access: Compounded Options at PlexusDx

Brand-name Ozempic (semaglutide) and Mounjaro (tirzepatide) can cost $900–$1,500+ monthly without insurance. PlexusDx sources compounded semaglutide injections from licensed 503A pharmacies starting at $149 per month, and compounded tirzepatide injections starting at $249 per month. Both are HSA/FSA eligible and available in all 50 states without membership fees or insurance requirements.

If you want both peptides in one injection, PlexusDx offers GLP-Squared Injection (semaglutide + tirzepatide combination) starting at $249 monthly. Oral formulations are also available for patients who prefer pills over injections, though they require higher doses to achieve comparable absorption.

Side Effects and Safety: What to Expect

Both medications share common GLP-1 side effects: nausea, constipation, and reduced appetite (which is therapeutic but can feel intense early on). Tirzepatide may cause slightly higher rates of nausea during dose escalation because it activates two pathways, though most patients adjust within 2–4 weeks. Serious complications like pancreatitis are rare but require immediate medical attention.

Compounded medications from PlexusDx's licensed 503A pharmacies meet the same quality and sterility standards as brand-name injectables. Your PlexusDx clinician monitors your response and adjusts dosing to minimize side effects while maximizing weight-loss results. If one compound causes unmanageable symptoms, switching to the other is straightforward.

How Genetic Testing Guides Your Choice

The GLP1R rs6923761 variant, for example, can influence how strongly your brain responds to semaglutide. Similarly, the GIPR rs1800437 variant affects how much benefit you may gain from tirzepatide's dual-hormone approach. Carrying certain variants doesn't mean one drug won't work—it means your clinician can anticipate your likely response and choose starting doses more strategically.

PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first month of treatment) maps 14 metabolic pathways across 49 peptides and 150+ genetic insights. This personalized roadmap helps your clinician predict whether you'll respond better to semaglutide, tirzepatide, or a combination, reducing months of guesswork and optimizing your weight-loss journey from day one.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Which medication causes faster weight loss—semaglutide or tirzepatide?

Tirzepatide typically produces faster and greater average weight loss because it activates two appetite-control pathways instead of one. Clinical trials show tirzepatide users lose 20–22% of body weight compared to 15–17% with semaglutide, but individual results depend on your genetics, metabolism, and adherence to the program.

Can I switch from semaglutide to tirzepatide if I'm not seeing results?

Yes. If you've been on semaglutide for 8–12 weeks without desired progress, your PlexusDx clinician can transition you to tirzepatide. The switch typically happens over 1–2 weeks to avoid overlapping dosing. Many patients find tirzepatide more effective, especially if genetic testing shows you have variants that favor GIP-pathway activation.

How much does compounded tirzepatide cost at PlexusDx?

Compounded tirzepatide injection starts at $249 per month across all commitment levels—your dose may increase, but your price stays the same. This is significantly less than brand-name Mounjaro ($900–$1,500+), and the medication comes from the same licensed 503A compounding pharmacies used by hospitals nationwide.

Are compounded semaglutide and tirzepatide as safe as brand-name versions?

Yes. PlexusDx sources all compounded medications from licensed 503A pharmacies, which operate under strict FDA oversight for sterility, strength, and purity. The active compounds are identical to brand names; compounding simply allows for personalized dosing and lower costs. Your clinician monitors you just as closely as with brand-name therapy.

How does the Precision Peptide Genetic Test help me choose between semaglutide and tirzepatide?

The test identifies your genetic variants in GLP1R, GIPR, FTO, and MC4R genes, revealing whether you're likely to respond stronger to single-pathway (semaglutide) or dual-pathway (tirzepatide) therapy. This insight lets your PlexusDx clinician recommend the right starting medication and dose, avoiding weeks of trial-and-error and maximizing your weight-loss success from the beginning.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves